HER2 Signaling Modulates the Equilibrium Between Pro- And Antiangiogenic Factors via Distinct Pathways: Implications for HER2-targeted Antibody Therapy

Oncogene - United Kingdom
doi 10.1038/sj.onc.1209685
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy